News Archive

SomaLogic joins UK Dementias Research Platform

SomaLogic announced today that is a launch partner of the Medical Research Council’s UK Dementias Research Platform, a $27 million public-private partnership set up to speed up research into dementias. The collaboration aims to enable earlier detection, improved treatment and, ultimately, prevention of the disease, by looking not just at what is going wrong in the brain, but at the brain in the context of the whole body.

read more

SomaLogic scientists and colleagues publish two papers describing IL-6 SOMAmers

In a pair of papers published in the Journal of Biological Chemistry, a group of SomaLogic researchers and their colleagues at Otsuka Pharmaceuticals and Emerald Bio describe the development of new SOMAmer reagents that can block signaling by interleukin-6 (a critical protein involved in inflammation and cancer), as well as the structural interaction of the two molecules.

read more